Lixelle adsorbent to remove inflammatory cytokines

Artificial Organs

Volumn 22, Issue 12, 1998, Pages 1064-1067

  Tsuchida, Kenji ^a   Takemoto, Yoshiaki ^a   Nakamura, Takahiro ^a   Fu, Ontaku ^a   Okada, Chikako ^a   Yamagami, Seiji ^a   Kishimoto, Taketoshi ^a  

^a OSAKA CITY UNIVERSITY HOSPITAL   (Japan)

Author keywords

Adsorption; Inflammatory cytokines; Lixelle

Indexed keywords

DIALYSIS; GLYCOPROTEINS;

CYTOKINES; DIALYSIS-RELATED AMYLOIDOSIS; HEMODIALYSIS PATIENT; HEMOPERFUSION; INFLAMMATORY CYTOKINES; INTERLEUKIN1; INTERLEUKIN6 (IL6); LIXELLE; SELECTIVE ADSORBENTS; SERUM LEVELS;

PATIENT TREATMENT;

BETA 2 MICROGLOBULIN; CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 6; LIXELLE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ADSORPTION; ADSORPTION CHROMATOGRAPHY; ADULT; AMYLOIDOSIS; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CYTOKINE PRODUCTION; HEMODIALYSIS; HEMOFILTRATION; HUMAN; INFLAMMATION; PRIORITY JOURNAL; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 0031672461     PISSN: 0160564X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1594.1998.06179.x     Document Type: Article

References (15)

1. 2-microglobin. Ther Plasmapheresis 1993;12:779-83.
2. 2-microglobin adsorbent column. Int J Artif Organs 1993;16(12): 823-9.
3. 2-microglobin as a new form of amyloid protein in patients undergoing long-term hemodialysis. N Engl J Med 1986;314: 585-6.
4. Dayer JM, de Rochemonteix B, Burrus B, Dewmcruk S, Dinarello CA. Human recombinant interleukin 1 stimulates collagenase and prostaglandin E production by human synovial cells. J Clin Invest 1986;77:645-8.
5. Dewhirst FE, Stashenko PP, Mole JE, Tsurumachi T. Purification and partial sequence of human osteoblast-activating factor: Identity with interleukin 1β. J Immunol 1985;135: 2562-8.
6. Miyasaka N, Sato K, Hashimoto J. Constitutive production of interleukin 6/B cell stimulatory factor-2 from inflammatory synovium. Clin Immunol Immunopathol 1989;52:238-7.
7. 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis. J Clin Invest 1993;92:1243-52.
8. 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis. J Clin Invest 1994;93: 521-8.
9. 2-microglobulin amyloid deposition in the vertebral column. Kidney Int 1992;41(6):1646-52.
10. 2-microglobulin. Biophys Res Commun 1985;129:701-6.
11. van Ypersele der Strihou C, Jadoul M, Malghem J. Effect of dialysis membrane and patient's age on signs of dialysis-related amyloidosis. Kidney Int 1991;39:1012-9.
12. Kim ST. Characteristics of protein removal in hemodiafiltration. Contrib Nephrol 1994;108:23-37.
13. Maeda K, Kobayakawa H, Fujita H. Effectiveness of push/ pull hemodiafiltration using large-pore membrane for shoulder joint pain in long-term dialysis patients. Artif Organs 1990;14:321-7.
14. Henderson LW, Koch KM, Dinarello CA, Shaldon S. Hemodialysis hypotension: The interleukin hypothesis. Blood Purif 1983;1:3-8.
15. Gejyo F, Homma N, Arakawa M. Long-term complications of dialysis: Pathogenic factors with special reference to amyloidosis. Kidney Int 1993;43(Suppl. 41):S78-82.